Insider Trading - Civik Thomas
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-16 Purchase | 2021-11-18 5:00 pm | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 7,500 | $28.08 | $210,600 | 7,500 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-19 1:21 pm | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 15,700 | $12.74 | $200,018 | 15,700 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-01-01 Option Award | 2018-01-03 4:07 pm | N/A N/A | Foundation Medicine Inc. | FMI | Civik Thomas Chief Commercial Officer | 33,421 | $68.2 | 33,421 (Direct) | View |
| 2018-07-31 Other | 2018-08-02 4:03 pm | N/A N/A | Foundation Medicine Inc. | FMI | Civik Thomas Chief Commercial Officer | 33,421 | $137 | 33,421 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-14 4:38 pm | N/A 2030-04-12 | FIVE PRIME THERAPEUTICS Inc | FPRX | Civik Thomas CEO | 555,000 | $0 | 555,000 (Direct) | View |
| 2021-04-09 Tax Withholding | 2021-04-13 1:05 pm | N/A N/A | FIVE PRIME THERAPEUTICS Inc | FPRX | Civik Thomas CEO | 11,088 | $37.94 | 68,971 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:21 pm | N/A N/A | FIVE PRIME THERAPEUTICS Inc | FPRX | Civik Thomas CEO | 480,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:21 pm | N/A N/A | FIVE PRIME THERAPEUTICS Inc | FPRX | Civik Thomas CEO | 68,971 | $38 | 0 (Direct) | View |
| 2021-09-07 Option Award | 2021-09-09 5:06 pm | N/A 2031-09-07 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 42,191 | $0 | 42,191 (Direct) | View |